vs
Celsius Holdings, Inc.（CELH）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Celsius Holdings, Inc.的季度营收约是Healthpeak Properties的1.0倍（$721.6M vs $702.9M），Healthpeak Properties净利率更高（51.6% vs 3.4%，领先48.2%），Celsius Holdings, Inc.同比增速更快（117.2% vs -6.6%），过去两年Celsius Holdings, Inc.的营收复合增速更高（42.4% vs 0.5%）
Celsius Holdings Inc.是美国功能饮品企业，旗下Celsius品牌主打健身饮料、能量饮品系列，产品主打健康定位，公司CEO曾表示这一差异化优势是品牌取得市场成功的核心原因。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CELH vs DOC — 直观对比
营收规模更大
CELH
是对方的1.0倍
$702.9M
营收增速更快
CELH
高出123.9%
-6.6%
净利率更高
DOC
高出48.2%
3.4%
两年增速更快
CELH
近两年复合增速
0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $721.6M | $702.9M |
| 净利润 | $24.7M | $363.0M |
| 毛利率 | 47.4% | — |
| 营业利润率 | 3.6% | 0.7% |
| 净利率 | 3.4% | 51.6% |
| 营收同比 | 117.2% | -6.6% |
| 净利润同比 | 231.1% | 28.3% |
| 每股收益（稀释后） | $0.04 | $0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CELHDOC
| Q1 26 | — | $702.9M | ||
| Q4 25 | $721.6M | $719.4M | ||
| Q3 25 | $725.1M | $705.9M | ||
| Q2 25 | $739.3M | $694.3M | ||
| Q1 25 | $329.3M | $702.9M | ||
| Q4 24 | $332.2M | $698.0M | ||
| Q3 24 | $265.7M | $700.4M | ||
| Q2 24 | $402.0M | $695.5M |
净利润CELHDOC
| Q1 26 | — | $363.0M | ||
| Q4 25 | $24.7M | $114.0M | ||
| Q3 25 | $-61.0M | $-117.1M | ||
| Q2 25 | $99.9M | $31.7M | ||
| Q1 25 | $44.4M | $42.8M | ||
| Q4 24 | $-18.9M | $4.5M | ||
| Q3 24 | $6.4M | $85.9M | ||
| Q2 24 | $79.8M | $146.0M |
毛利率CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | 47.4% | — | ||
| Q3 25 | 51.3% | 58.6% | ||
| Q2 25 | 51.5% | 60.2% | ||
| Q1 25 | 52.3% | 61.1% | ||
| Q4 24 | 50.2% | 60.3% | ||
| Q3 24 | 46.0% | 60.0% | ||
| Q2 24 | 52.0% | 60.6% |
营业利润率CELHDOC
| Q1 26 | — | 0.7% | ||
| Q4 25 | 3.6% | 17.4% | ||
| Q3 25 | -11.0% | 9.2% | ||
| Q2 25 | 19.3% | 5.7% | ||
| Q1 25 | 15.8% | 7.7% | ||
| Q4 24 | -5.6% | -2.2% | ||
| Q3 24 | -1.2% | 14.1% | ||
| Q2 24 | 23.4% | 22.3% |
净利率CELHDOC
| Q1 26 | — | 51.6% | ||
| Q4 25 | 3.4% | 73.2% | ||
| Q3 25 | -8.4% | -16.6% | ||
| Q2 25 | 13.5% | 4.6% | ||
| Q1 25 | 13.5% | 6.1% | ||
| Q4 24 | -5.7% | 0.7% | ||
| Q3 24 | 2.4% | 12.3% | ||
| Q2 24 | 19.8% | 21.0% |
每股收益（稀释后）CELHDOC
| Q1 26 | — | $0.28 | ||
| Q4 25 | $0.04 | $0.16 | ||
| Q3 25 | $-0.27 | $-0.17 | ||
| Q2 25 | $0.33 | $0.05 | ||
| Q1 25 | $0.15 | $0.06 | ||
| Q4 24 | $-0.10 | $0.02 | ||
| Q3 24 | $0.00 | $0.12 | ||
| Q2 24 | $0.28 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $398.9M | $-1.2B |
| 总债务越低越好 | $676.9M | — |
| 股东权益账面价值 | $1.2B | $7.8B |
| 总资产 | $5.1B | $21.6B |
| 负债/权益比越低杠杆越低 | 0.57× | — |
8季度趋势，按日历期对齐
现金及短期投资CELHDOC
| Q1 26 | — | $-1.2B | ||
| Q4 25 | $398.9M | $467.5M | ||
| Q3 25 | $806.0M | $91.0M | ||
| Q2 25 | $615.2M | $89.4M | ||
| Q1 25 | $977.3M | $70.6M | ||
| Q4 24 | $890.2M | $119.8M | ||
| Q3 24 | $903.7M | $180.4M | ||
| Q2 24 | $903.2M | $106.9M |
总债务CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | $676.9M | $9.8B | ||
| Q3 25 | $870.5M | $9.1B | ||
| Q2 25 | $871.9M | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B |
股东权益CELHDOC
| Q1 26 | — | $7.8B | ||
| Q4 25 | $1.2B | $7.5B | ||
| Q3 25 | $1.2B | $7.6B | ||
| Q2 25 | $1.3B | $7.9B | ||
| Q1 25 | $443.1M | $8.2B | ||
| Q4 24 | $399.9M | $8.4B | ||
| Q3 24 | $423.6M | $8.6B | ||
| Q2 24 | $415.8M | $8.8B |
总资产CELHDOC
| Q1 26 | — | $21.6B | ||
| Q4 25 | $5.1B | $20.3B | ||
| Q3 25 | $5.3B | $19.6B | ||
| Q2 25 | $3.8B | $19.8B | ||
| Q1 25 | $1.9B | $19.8B | ||
| Q4 24 | $1.8B | $19.9B | ||
| Q3 24 | $1.7B | $20.0B | ||
| Q2 24 | $1.7B | $20.2B |
负债/权益比CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | 0.57× | 1.31× | ||
| Q3 25 | 0.72× | 1.20× | ||
| Q2 25 | 0.69× | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-119.4M | — |
| 自由现金流经营现金流 - 资本支出 | $-130.0M | — |
| 自由现金流率自由现金流/营收 | -18.0% | — |
| 资本支出强度资本支出/营收 | 1.5% | 3.4% |
| 现金转化率经营现金流/净利润 | -4.83× | — |
| 过去12个月自由现金流最近4个季度 | $323.4M | — |
8季度趋势，按日历期对齐
经营现金流CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | $-119.4M | $1.3B | ||
| Q3 25 | $331.8M | $315.0M | ||
| Q2 25 | $43.7M | $363.5M | ||
| Q1 25 | $103.4M | $279.4M | ||
| Q4 24 | $75.7M | $1.1B | ||
| Q3 24 | $12.9M | $318.2M | ||
| Q2 24 | $39.6M | $316.2M |
自由现金流CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | $-130.0M | $357.0M | ||
| Q3 25 | $321.5M | — | ||
| Q2 25 | $35.5M | — | ||
| Q1 25 | $96.4M | — | ||
| Q4 24 | $70.3M | $333.7M | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $30.4M | — |
自由现金流率CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | -18.0% | 49.6% | ||
| Q3 25 | 44.3% | — | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | 29.3% | — | ||
| Q4 24 | 21.2% | 47.8% | ||
| Q3 24 | 3.3% | — | ||
| Q2 24 | 7.6% | — |
资本支出强度CELHDOC
| Q1 26 | — | 3.4% | ||
| Q4 25 | 1.5% | 124.4% | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 1.6% | 105.6% | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 2.3% | — |
现金转化率CELHDOC
| Q1 26 | — | — | ||
| Q4 25 | -4.83× | 10.99× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.44× | 11.48× | ||
| Q1 25 | 2.33× | 6.52× | ||
| Q4 24 | — | 235.43× | ||
| Q3 24 | 2.03× | 3.71× | ||
| Q2 24 | 0.50× | 2.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CELH
暂无分部数据
DOC
| Outpatient Medical | $320.5M | 46% |
| Lab | $217.6M | 31% |
| Senior Housing | $148.9M | 21% |
| Other | $14.3M | 2% |
| Corporate Non-segment | $1.5M | 0% |
